Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangements.
1 Department of Medical Oncology, Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy ; 2 Section of Pathologic Anatomy, University Hospital Policlinico of Modena, Modena, Italy ; 3 Division of Medical Oncology, University Hospital of Parma, Parma, Italy.
Francesco
F
Gelsomino
1 Department of Medical Oncology, Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy ; 2 Section of Pathologic Anatomy, University Hospital Policlinico of Modena, Modena, Italy ; 3 Division of Medical Oncology, University Hospital of Parma, Parma, Italy.
Giulio
G
Rossi
1 Department of Medical Oncology, Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy ; 2 Section of Pathologic Anatomy, University Hospital Policlinico of Modena, Modena, Italy ; 3 Division of Medical Oncology, University Hospital of Parma, Parma, Italy.
Marcello
M
Tiseo